BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

542 related articles for article (PubMed ID: 18992055)

  • 1. Rapid full engraftment and successful immune reconstitution after allogeneic hematopoietic stem cell transplantation with reduced intensity conditioning in Omenn syndrome.
    Gozdzik J; Czogala W; Skoczen S; Krasowska-Kwiecien A; Wiecha O; Mordel A; Lesko E; Majka M; Kowalczyk D; Zembala M
    Pediatr Transplant; 2009 Sep; 13(6):760-5. PubMed ID: 18992055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful allogeneic stem cell transplant for leukocyte adhesion deficiency using an adjusted busulfan-containing regimen.
    Yoshimoto A; Hashii Y; Kashiwagi H; Koizumi M; Tokimasa S; Fujisaki H; Ohta H; Hanai N; Ozono K; Hara J
    Pediatr Transplant; 2007 Jun; 11(4):453-5. PubMed ID: 17493230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone marrow transplantation without conditioning regimen in Omenn syndrome: a case report.
    Mellouli F; Torjmen L; Ksouri H; Abdelkefi A; Ladab S; Barbouche R; Othman TB; Hassen AB; Bejaoui M
    Pediatr Transplant; 2007 Dec; 11(8):922-6. PubMed ID: 17976129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multilineage hematopoietic engraftment after allogeneic peripheral blood stem cell transplantation without conditioning in SCID patients.
    Bielorai B; Trakhtenbrot L; Amariglio N; Rothman R; Tabori U; Dallal I; Golan H; Neumann Y; Reichart M; Kaplinsky C; Rechavi G; Toren A
    Bone Marrow Transplant; 2004 Aug; 34(4):317-20. PubMed ID: 15220954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel adopted immunotherapy for mixed chimerism after unrelated cord blood transplantation in Omenn syndrome.
    Tomizawa D; Aoki Y; Nagasawa M; Morio T; Kajiwara M; Sekine T; Shimizu N; Kato M; Yachie A; Mizutani S
    Eur J Haematol; 2005 Nov; 75(5):441-4. PubMed ID: 16191096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful treatment of primary plasma cell leukaemia by allogeneic stem cell transplantation from haploidentical sibling.
    Nonami A; Miyamoto T; Kuroiwa M; Kunisaki Y; Kamezaki K; Takenaka K; Harada N; Teshima T; Harada M; Nagafuji K
    Jpn J Clin Oncol; 2007 Dec; 37(12):969-72. PubMed ID: 18055567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful allogeneic hematopoietic stem cell transplantation (HSCT) for Shwachman-Diamond syndrome.
    Fleitz J; Rumelhart S; Goldman F; Ambruso D; Sokol RJ; Pacini D; Quinones R; Holida M; Lee N; Tannous R; Giller R
    Bone Marrow Transplant; 2002 Jan; 29(1):75-9. PubMed ID: 11840149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reticular dysgenesis: HLA non-identical bone marrow transplants in a series of 10 patients.
    Bertrand Y; Müller SM; Casanova JL; Morgan G; Fischer A; Friedrich W
    Bone Marrow Transplant; 2002 May; 29(9):759-62. PubMed ID: 12040473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hematopoietic stem cell transplantation for severe combined immunodeficiency diseases.
    Cowan MJ; Neven B; Cavazanna-Calvo M; Fischer A; Puck J
    Biol Blood Marrow Transplant; 2008 Jan; 14(1 Suppl 1):73-5. PubMed ID: 18162224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hematopoietic stem cell transplantation for severe combined immune deficiency or what the children have taught us.
    Rappeport JM; O'Reilly RJ; Kapoor N; Parkman R
    Immunol Allergy Clin North Am; 2010 Feb; 30(1):17-30. PubMed ID: 20113884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden.
    Warlick ED; Cioc A; Defor T; Dolan M; Weisdorf D
    Biol Blood Marrow Transplant; 2009 Jan; 15(1):30-8. PubMed ID: 19135940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From Severe Combined Immunodeficiency to Omenn syndrome after hematopoietic stem cell transplantation in a RAG1 deficient family.
    Martinez-Martinez L; Vazquez-Ortiz M; Gonzalez-Santesteban C; Martin-Nalda A; Vicente A; Plaza AM; Badell I; Alsina L; de la Calle-Martin O
    Pediatr Allergy Immunol; 2012 Nov; 23(7):660-6. PubMed ID: 22882342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequential intensified conditioning and tapering of prophylactic immunosuppressants for graft-versus-host disease in allogeneic hematopoietic stem cell transplantation for refractory leukemia.
    Liu QF; Fan ZP; Zhang Y; Jiang ZJ; Wang CY; Xu D; Sun J; Xiao Y; Tan H
    Biol Blood Marrow Transplant; 2009 Nov; 15(11):1376-85. PubMed ID: 19822296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unrelated hematopoietic stem cell transplantation for Cernunnos-XLF deficiency.
    Faraci M; Lanino E; Micalizzi C; Morreale G; Di Martino D; Banov L; Comoli P; Locatelli F; Soresina A; Plebani A
    Pediatr Transplant; 2009 Sep; 13(6):785-9. PubMed ID: 19067926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-myeloablative stem cell transplantation for severe combined immunodeficiency--Omenn syndrome.
    Rossi G; Zecca M; Giorgiani G; Bonetti F; De Stefano P; Locatelli F
    Br J Haematol; 2004 May; 125(3):406-7. PubMed ID: 15086425
    [No Abstract]   [Full Text] [Related]  

  • 16. Mismatched bone marrow transplantation for Omenn syndrome: a variant of severe combined immunodeficiency.
    Loechelt BJ; Shapiro RS; Jyonouchi H; Filipovich AH
    Bone Marrow Transplant; 1995 Sep; 16(3):381-5. PubMed ID: 8535310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current indications for reduced-intensity allogeneic stem cell transplantation.
    Haddad N; Rowe JM
    Best Pract Res Clin Haematol; 2004 Sep; 17(3):377-86. PubMed ID: 15498710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of antithymocyte globulin and granulocyte-colony stimulating factor-mobilized bone marrow in allogeneic transplantation for patients with hematologic malignancies.
    Chen XH; Zhang C; Zhang X; Gao L; Gao L; Kong PY; Peng XG; Qi DG; Sun AH; Zeng DF; Liu H; Gong Y; Wang QY
    Biol Blood Marrow Transplant; 2009 Feb; 15(2):266-73. PubMed ID: 19167687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk assessment in haematopoietic stem cell transplantation: stem cell source.
    Urbano-Ispizua A
    Best Pract Res Clin Haematol; 2007 Jun; 20(2):265-80. PubMed ID: 17448961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced intensity hematopoietic stem-cell transplantation across human leukocyte antigen barriers in a patient with congenital amegakaryocytic thrombocytopenia and monosomy 7.
    Steele M; Hitzler J; Doyle JJ; Germeshausen M; Fernandez CV; Yuille K; Dror Y
    Pediatr Blood Cancer; 2005 Aug; 45(2):212-6. PubMed ID: 15782403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.